{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":4,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":4,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"f11415678379","filters":{"venue":"Rare Disease and Orphan Drugs Journal"}},"results":[{"id":"W4226226005","doi":"10.20517/rdodj.2022.01","title":"Enhancing the value of clinical networks for rare diseases","year":2022,"lang":"en","type":"article","venue":"Rare Disease and Orphan Drugs Journal","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Standards Association","funders":"","keywords":"Legitimacy; Health care; Knowledge management; Public relations; Diversity (politics); Best practice; Medicine; Political science; Computer science","authors":[{"name":"Matthew Bolz-Johnson","is_ca":false},{"name":"Louise Clément","is_ca":true},{"name":"William A. Gahl","is_ca":false},{"name":"Carmencita D. Padilla","is_ca":false},{"name":"Yukiko Nishumura","is_ca":false},{"name":"Peirong Yang","is_ca":false},{"name":"Lisa Sarfaty","is_ca":false},{"name":"Gareth Baynam","is_ca":false},{"name":"Thomas Kenny","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0097746278647512,"gpt":0.2818339027353585,"spread":0.2720592748706073,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03799533,0.0003903098,0.0005229324,0.002523891,0.004607473,0.01248129,0.002224942,0.003185011,0.009935498],"category_scores_gemma":[0.09415352,0.0004024649,0.0008691748,0.001803039,0.006895148,0.01717759,0.01566151,0.003674846,0.001149043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007389963,"about_ca_system_score_gemma":0.01903206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001766404,"about_ca_topic_score_gemma":0.004284364,"domain_scores_codex":[0.9423444,0.05034706,0.001212838,0.001316084,0.003525736,0.001253691],"domain_scores_gemma":[0.8437394,0.1262265,0.009264234,0.003609633,0.006851346,0.01030887],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0001300576,0.0001625728,0.008031731,0.01153515,0.000203376,0.002334872,0.09894094,0.0009972793,0.0007352898,0.2064998,0.05934466,0.6110843],"study_design_scores_gemma":[0.00007128315,0.0002525966,0.005277148,0.02053776,0.0001579178,0.001936079,0.04557535,0.0005937944,0.0005248164,0.06954377,0.8554527,0.00007684171],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.07320685,0.1621963,0.03649801,0.4245191,0.00618299,0.001171707,0.0003145013,0.0003614003,0.2955492],"genre_scores_gemma":[0.8450183,0.07867835,0.03045577,0.02988972,0.002799397,0.0009485268,0.0002369103,0.0001509786,0.01182215],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03799533,"threshold_uncertainty_score":0.200941,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4367019825","doi":"10.20517/rdodj.2023.04","title":"Sustainable approaches for drug repurposing in rare diseases: recommendations from the IRDiRC Task Force","year":2023,"lang":"en","type":"article","venue":"Rare Disease and Orphan Drugs Journal","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadiana.org","funders":"","keywords":"Repurposing; Drug repositioning; Identification (biology); Medicine; Sustainability; Task (project management); Task force; Drug development; Business; Drug; Pharmacology; Engineering; Political science","authors":[{"name":"Galliano Zanello","is_ca":false},{"name":"Diego Ardigò","is_ca":false},{"name":"Florence Guillot","is_ca":false},{"name":"Anneliene Hechtelt Jonker","is_ca":false},{"name":"Oxana Iliach","is_ca":true},{"name":"Hervé Nabarette","is_ca":false},{"name":"Daniel O’Connor","is_ca":false},{"name":"Virginie Hivert","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04927013266708733,"gpt":0.3354894228361923,"spread":0.2862192901691049,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1744301,0.003547125,0.004094034,0.009941543,0.007145417,0.01443042,0.01546471,0.039614,0.009937122],"category_scores_gemma":[0.106435,0.001999059,0.007507635,0.0069722,0.008177418,0.0127932,0.01819965,0.02942113,0.007758707],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01488657,"about_ca_system_score_gemma":0.176677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04440653,"about_ca_topic_score_gemma":0.0383136,"domain_scores_codex":[0.9036798,0.04144724,0.01521757,0.00312695,0.02316641,0.01336205],"domain_scores_gemma":[0.7559246,0.1030503,0.01493122,0.007306638,0.09004033,0.02874682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001305005,0.001236583,0.002461869,0.0098982,0.00009951791,0.001074562,0.004618166,0.00192121,0.001519245,0.01897304,0.7520602,0.2060068],"study_design_scores_gemma":[0.0001674418,0.0002356907,0.003095863,0.03600252,0.000136601,0.0004514814,0.006911872,0.0008735534,0.0004706107,0.009618325,0.941808,0.0002279268],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.001876921,0.04890143,0.009357738,0.9083041,0.01060226,0.002606137,0.0007539165,0.0005251535,0.01707235],"genre_scores_gemma":[0.02804683,0.1484956,0.2589964,0.4976355,0.009068057,0.0174244,0.005445953,0.0007524364,0.03413481],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.1744301,"threshold_uncertainty_score":0.9224854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400570519","doi":"10.20517/rdodj.2023.61","title":"Fabry nephropathy: a treatable cause of chronic kidney disease","year":2024,"lang":"en","type":"article","venue":"Rare Disease and Orphan Drugs Journal","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Globotriaosylceramide; Medicine; Fabry disease; Enzyme replacement therapy; Proteinuria; Albuminuria; Nephropathy; Kidney disease; Alpha-galactosidase; Internal medicine; Podocyte; Cardiomyopathy; Dialysis; Glomerular basement membrane; Kidney; Disease; Heart failure; Pathology; Urology; Endocrinology; Diabetes mellitus","authors":[{"name":"Michael L. West","is_ca":true},{"name":"Laurette Geldenhuys","is_ca":true},{"name":"Daniel G. Bichet","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01343904179696902,"gpt":0.2903369501416745,"spread":0.2768979083447055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003104805,0.0004258675,0.0008728831,0.0004773324,0.0006363749,0.0005221502,0.0004614508,0.0008763908,0.003886389],"category_scores_gemma":[0.0004779144,0.00006544161,0.0003222048,0.0006665158,0.0002233763,0.000278223,0.0005660076,0.0007006377,0.001228279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005486965,"about_ca_system_score_gemma":0.0006928579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001711733,"about_ca_topic_score_gemma":0.001425017,"domain_scores_codex":[0.9997635,0.0000441718,0.00001667703,0.00003655112,0.00006894747,0.00007003317],"domain_scores_gemma":[0.9998682,0.0000182497,0.00003257657,0.000007637032,0.00002598579,0.00004735792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008918391,0.0008290798,0.03939544,0.004131175,0.0003911055,0.0409964,0.0003893642,0.0005291087,0.01888173,0.007057787,0.1015997,0.7849073],"study_design_scores_gemma":[0.0003811705,0.001162574,0.09448082,0.004165809,0.0008416871,0.2286647,0.0005734339,0.001372146,0.006292833,0.009661253,0.6523194,0.00008414109],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1633215,0.7446303,0.01261429,0.01831937,0.001648799,0.0003190869,0.001844109,0.001123663,0.05617876],"genre_scores_gemma":[0.7480804,0.2126041,0.005326959,0.007783416,0.002553519,0.0001876975,0.002598771,0.00008129725,0.02078388],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003886389,"threshold_uncertainty_score":0.01300132,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400098184","doi":"10.20517/rdodj.2024.14","title":"Longitudinal biomarker evaluation in Fabry disease patients receiving lentivirus-mediated gene therapy","year":2024,"lang":"en","type":"article","venue":"Rare Disease and Orphan Drugs Journal","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôpital Fleurimont","funders":"","keywords":"Globotriaosylceramide; Fabry disease; Enzyme replacement therapy; Genetic enhancement; Medicine; Biomarker; Urine; Internal medicine; Alpha-galactosidase; Urology; Disease; Gastroenterology; Oncology; Gene; Biology","authors":[{"name":"Christiane Auray‐Blais","is_ca":false},{"name":"Paméla Lavoie","is_ca":false},{"name":"Tristan Martineau","is_ca":false},{"name":"C. Anthony Rupar","is_ca":false},{"name":"Dwayne L. Barber","is_ca":false},{"name":"Armand Keating","is_ca":false},{"name":"Ronan Foley","is_ca":false},{"name":"Michael L. West","is_ca":false},{"name":"Jeffrey A. Medin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03650465092311914,"gpt":0.3265417238837958,"spread":0.2900370729606767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001122288,0.0002375016,0.0004277978,0.0005415819,0.0008294015,0.0006477259,0.0002992492,0.000354631,0.0005115707],"category_scores_gemma":[0.001048929,0.0001121997,0.0002415477,0.0006665746,0.0002344855,0.0002326999,0.0002634846,0.0004620946,0.0001213943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001350264,"about_ca_system_score_gemma":0.001420458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03144408,"about_ca_topic_score_gemma":0.03682659,"domain_scores_codex":[0.9996146,0.00007394732,0.00001983245,0.00007397433,0.0001287715,0.0000888594],"domain_scores_gemma":[0.9992894,0.00004860662,0.0002196832,0.00002706365,0.0002650661,0.0001501519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001389743,0.0002065639,0.9784572,0.00003470786,0.00006584988,0.0002032736,0.0004267935,0.00007143309,0.007643172,0.00002621519,0.0002544875,0.01122056],"study_design_scores_gemma":[0.00002058352,0.00148807,0.9942995,0.00001310438,0.0000715414,0.0002825572,0.0003184551,0.0002216324,0.002173604,0.00002236566,0.001079803,0.000008702735],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984792,0.000616674,0.0001792444,0.00005116211,0.000004897669,0.00004129613,0.0002405195,0.000009170859,0.0003778417],"genre_scores_gemma":[0.9985863,0.0001976895,0.0003427117,0.00008101015,0.000005021826,0.00002725763,0.000415435,0.000001831182,0.0003427533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03144408,"threshold_uncertainty_score":0.06252211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}